I wrote about this company a while ago. Recently they had a press release about them announcing the first delivery of Actinium-225, a rare but promising cancer-fighting radio-isotope to the National Cancer Institute, a part of the National Institutes of Health (NIH), the federal government’s leading medical research organization. I have to tell you, the more I know about this company, the more I become more interested in investing in it. Of course, I’ve said so many times to myself that I would never invest in anything that’s traded at more than $1/share. But this one…Mmm looks like it becomes more and more appealing.

Here’s their price/share chart (starting from February 2004 - January 2005)

I know the price fluctuated a bit in the past 3 months, but hey it went up from under $2/share in September 2004 to $6/share in December. And I think 2005 should be a good year for them since they somehow decided to branch out to medical industry.

“…Isonics has received exclusive marketing and sales rights for all of the Actinium-225 produced by IPPE. Assuming that IPPE reaches target production levels over the next year, Isonics expects that this will nearly double the existing global supply of Actinium-225. Currently, research includes clinical trials for therapies for leukemia and lymphoma. Numerous pre-clinical results have been published demonstrating the potential application of Bismuth-213 as a therapeutic for metastatic disease, bone marrow transplant, as well as treatments of fungal and bacterial infection.
Independent medical researchers welcomed the projected Actinium supply increases. “Clinical results to date have looked very promising, but lack of availability of the isotope Actinium-225 and the present high cost for that which is available has greatly limited the research,” said Dr. Barbara Y. Croft, of the National Cancer Institute. “I am greatly encouraged that Isonics is working with IPPE to expand availability of Actinium-225, which will enable a greater number of promising research projects to proceed…”

That’s what they say in the article which was recently published in Business Wire. Very interesting, huh?

Quote of the Day:
Investors in the corporate bond market do not enjoy the same access to information as a car buyer or, dare I say, a fruit buyer. - SEC Chairman Arthur Levitt

…the price was $1.95/share when the market closed. It’s approaching $2 mark. Hmm…I have to say, I’m very tempted to put some money in this company. Looks like this one is going to hit $3 to $4 per share by the end of this year.

This company was profiled on MSN’s Money Central on September 29th, 2004. Solucorp was picked because it is the “potentially most rewarding — environmental stock on Money Central’s list … The tiny company has three areas of business, which may begin producing some relatively big revenue over the next six to 12 months.”

What does Solucorp Industries do?
SOLUCORP is an innovative developer of superior metals remediation technologies. The Company develops environmentally friendly technologies for the treatment and prevention of hazardous heavy metal contamination of waste streams. Solucorp owns two patents on its Molecular Bonding System (MBS(R)) technology, has applied for several patents including bullet traps, projectiles, paint strippers and filter material with its Integrated Fixation System (IFS) technology and has received a notice of allowance from the Patent Trademark Office (PTO) for the main IFS patent application. The effectiveness of the Company’s patented MBS is acknowledged by its successful completion of the U.S. EPA’s Superfund Innovative Technology Evaluation (SITE) Program. MBS has proven to cost effectively and permanently remediate heavy metals contamination in soils and industrial wastes and has been successfully used internationally.

In the past 3 months the stock has been fluctuating a lot - it went up as high as $3/share, then went down to $1/share in September until it finally climbed back up to $1.75/share. Yes, it is a bit risky investing in this company - but after reading their profile on MSN’s Money Central (title: “3 ‘green’ stocks that don’t care who’s president”), I was convinced that this could be a good long-term investment.

Here’s the URL if you want to see their profile:
http://moneycentral.msn.com/content/P92933.asp

Quote of the Day:
I’d compare stock pickers to astrologers, but I don’t want to bad-mouth the astrologers. - A leading efficient market theorist

Fellas,

Need to know more about Isonics Corp?
I’d suggest you click on this link, it’ll take you to the list of news/stories of Isonics Corp.

…Yes, that’s 62% increase, by the way. Went up by $2.11 in just one day. They even went up as high as $6.27/share until it finally settled at $5.48/share when the market closed.

If you go back to the blog that I wrote last Friday, I was predicting that this stock was going to hit $5/share by the end of the year. Well I guess I was wrong…It’s already more than $5/share now. And I think it’s going to keep going up - especially since they’re going to do public demonstration on their product on October 21st. If you want to invest in this company, I’d (again) strongly suggest to invest at this moment - before they’re doing public presentation on their product. Because I have a hunch that the price is going through the roof after the demonstration.

Would you like me refresh your memory again what they’re doing? Here it is:

Isonics Corporation has three business divisions: (1) Isonics Semiconductor, (2) Isonics Life Sciences, and (3) Homeland Security and Defense. Isonics is a world leader in isotopically engineered materials and through its semiconductor division produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. Through advances in nanotechnology, the Company is also focused on research and development opportunities for further, value-added product and application development. Isonics’ Life Sciences division markets and sellsstable isotopes for the health care industry such as carbon-13 for diagnostic breath tests and drug design, and radioisotopes and stable isotopes, such as oxygen-18 for positron emission tomography (PET) imaging. (Source Business Wire 2004)

And here’s the product that they’re going to present on October 21st:

The NeutroTest(TM) product is a portable, hand-held device designed to provide first-responders with a powerful tool for quickly and easily evaluating an explosive threat in the form of a suspicious package or purported explosive device. It was designed to be capable of detecting as little as 200 grams of TNT or other explosive material through 5 mm of steel.

This neutron-based technology is distinct from the x-ray scanning systems commonly used in package and suitcase security inspections, and provides unique types of information about the packages or cases being evaluated. X-rays simply detect shapes and density, and provide pictures of the contents of containers. Neutrons have the ability to provide information regarding the nature of the chemical composition while x-rays do not.

Isonics is positioning the NeutroTest(TM) as a moderately-priced, portable product for use by first-responders in bomb squads, airports, police departments, fire departments, customs agencies and security services worldwide. (Source: Business Wire 2004)

Remember! You invest in this company because of the product that they offer. Not because the stock is going up. The product is released at the right time, and yes there is huge market for their product. Think about it…

Quote of the Day:
The dumbest reason in the world to buy a stock is because it’s going up. - Warren Buffett